Utama › Karsinoma Urotelial (Sel Transisi) › California › Orange
Kajian klinikal Karsinoma Urotelial (Sel Transisi) di Orange, CA
10 kajian untuk Karsinoma Urotelial (Sel Transisi) sedang mencari peserta di lokasi dalam dan sekitar Orange (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
A Study Comparing the Combination of Pembrolizumab and Sacituzumab Govitecan-hziy Versus Standard of Care in the Treatment of Advanced Urothelial Cancer
Mengambil pesertaFasa 3
- UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange
A Substudy of Investigational Agents in Programmed Cell Death-1/Ligand 1 (PD-1/L1) Refractory Locally Advanced or Metastatic Urothelial Carcinoma (mUC) (MK-3475-04A)
Mengambil pesertaFasa 1/2
- University of California, Irvine (UCI) Health - UC Irvine Medical Center ( Site 1045), Orange
Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
Mengambil pesertaFasa 1/2
- UC Irvine Health, Orange
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Mengambil pesertaFasa 3
- University of California, Irvine (UCI) Health - UC Irvine Medical Center, Orange
Pembrolizumab Plus CA-4948 for the Treatment of Patients With Progressive Metastatic Urothelial Cancer Despite Prior Immunotherapy
Mengambil pesertaFasa 1
- UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange
A Phase 3 Single-arm Study of UGN-104 for the Treatment of Low-grade Upper Tract Urothelial Cancer
Mengambil pesertaFasa 3
- UC Irvine Health. Chao Family Comprehensive Cancer Center, Orange
Feasibility Study on the Effect of a Methionine-Reduced Diet on Serum Levels in Pts w/ Solid Tumors
Mengambil pesertaFasa awal 1
- Chao Family Comprehensive Cancer Center, University of California, Irvine, Orange
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
Mengambil pesertaFasa 2
- UC Irvine Health, Orange
Adjuvant Sacituzumab Govitecan and Nivolumab in Muscle-Invasive Urothelial Carcinoma at High-Risk Recurrence
Mengambil pesertaFasa 2
- Chao Family Comprehensive Cancer Center, University of California, Irvine, Orange
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Mengambil pesertaKajian pemerhatian
- Massive Bio SYNERGY-AI site, Orange
Kajian Karsinoma Urotelial (Sel Transisi) di bandar lain
- Nashville, TN23 kajian
- New York City, NY22 kajian
- Houston, TX19 kajian
- Dallas, TX18 kajian
- Edison, NJ18 kajian
- Los Angeles, CA17 kajian
- Queens, NY15 kajian
- Chicago, IL14 kajian
- Arlington, VA12 kajian
- Boston, MA11 kajian
- San Antonio, TX11 kajian
- Austin, TX10 kajian
Kajian lain di Orange
- Kanser Paru-paru Bukan Sel Kecil25 kajian
- Kanser Metastatik20 kajian
- Kanser Kolorektal16 kajian
- Kanser Ovari16 kajian
- Kanser Pankreas15 kajian
- Melanoma14 kajian
- Kanser Hati (Karsinoma Hepatoselular)14 kajian
- Kanser Payudara14 kajian
- Kanser Paru-paru14 kajian
- Kanser Prostat14 kajian
- Kanser Perut13 kajian
- Kanser (semua jenis)13 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.